Search Results
Jun 03, 2026, 08:00 ET CRC CEO Tom Zoda, Ph.D., Chairs ASCP 2026 Panel on Preventable Failure Risk in CNS Clinical Trials
multimedia:https://www.prnewswire.com/news-releases/crc-ceo-tom-zoda-phd-chairs-ascp-2026-panel-on-preventable-failure-risk-in-cns-clinical-trials-302790153.htmlSOURCE
More news about: Cognitive Research Corporation
Jun 03, 2026, 07:37 ET Newfound 'Switchboard' Helps the Brain Form New Memories Without Forgetting Older Ones
Gonzalez, Vöröslakos, Chen, and Buzsáki, NYU Langone researchers involved in the study were Deren Aykan; Nina Soto, PhD; Noam Nitzan, PhD; Rachel Swanson, PhD; and Mursel Karadas, PhD.About NYU Langone HealthNYU Langone Health is a fully integrated health system that consistently
More news about: NYU Grossman School of Medicine and NYU Langone Health
Jun 03, 2026, 07:05 ET ERMProtect Launches PCI PFI Retainer Program to Accelerate Payment Card Breach Response
outsourcing, and on-demand security consulting. The company's training division offers a 100+ module library of Security Awareness Training and in-person, PhD-led sessions that teach organizations how to protect data and incorporate better security.Learn more at
More news about: ERMProtect
Jun 03, 2026, 07:01 ET Leading National DME Provider Integrates Cirventis to Accelerate Patient Access
denials, and improve adherence."We are setting a new standard for how quickly patients get the equipment they need," said Prakriteswar Santikary, PhD, Cirventis Co-founder & CTO. "Embedding our AI-driven platform directly into DME fulfillment workflows removes barriers and enables record speed,
More news about: Cirventis
Jun 03, 2026, 06:26 ET Precision Cardiovascular Appoints Brian Fahey, Ph.D., as Independent Director to the Board
content:https://www.prnewswire.com/news-releases/precision-cardiovascular-appoints-brian-fahey-phd-as-independent-director-to-the-board-302790057.htmlSOURCE
More news about: Precision Cardiovascular
Jun 02, 2026, 12:00 ET Rise Therapeutics Completes Enrollment in Four-Week Dose Expansion Cohort for the R-2487 Rheumatoid Arthritis Clinical Trial
2 clinical development."This milestone represents a significant step forward in unlocking the value of the R-2487 program," said Gary Fanger, PhD, President and Chief Executive Officer of Rise Therapeutics. "Completion of the 4-week dosing expansion cohort reflects the strong execution of our clinical
More news about: Rise Therapeutics
Jun 02, 2026, 11:55 ET ShiraTronics Completes Enrollment in RELIEV-CM2 Pivotal Trial of Implantable Extracranial Neuromodulation Systems (IENs) for Chronic Migraine
firsthand how many people with chronic migraine remain inadequately served despite the real advances of recent years," said Samer Narouze, MD, PhD, and Brian Grosberg, MD, national co-principal investigators of the RELIEV-CM2 study. "Completing pivotal enrollment in a rigorous, randomized study
More news about: ShiraTronics, Inc.
Jun 02, 2026, 11:36 ET La nueva guía española adaptada culturalmente para el manejo de los síntomas del cáncer de mama metastásico se estrena en asco 2026
para garantizar que los pacientes hispanos y latinos se sientan atendidos, informados, capacitados y apoyados ", dijo la Dra.Veronica Vital, PhD, MSN, MLS, RN, presidenta de la Asociación Nacional de Enfermeras Hispanas (NAHN).Desarrollada en colaboración con personas que viven con
More news about: Viver Health
Jun 02, 2026, 11:24 ET Camp Safety, Preparedness, and Protecting America's Youth
Camp AssociationSterling Nell Leija, American Camp Association Interim Chief of Staff and Innovative Camp Company CofounderEd Kearns, PhD, Chief Science Officer, First StreetSteve Baskin, American Camp Association Board Chair and Camp Champions, TexasAt this event,
More news about: American Camp Association
Jun 02, 2026, 11:00 ET Fingerpaint Group Names Sarah Cherng as Chief Technology & Product Officer Role
KNOLLS, N.J., June 2, 2026 /PRNewswire/ -- Fingerpaint Group today announced the appointment of Sarah Cherng, PhD, MPH, as Chief Technology & Product Officer. Reporting directly to CEO Bill McEllen, Cherng brings over 20 years of enterprise data science and AI/machine
More news about: Fingerpaint Group
Jun 02, 2026, 10:23 ET Stelexis BioSciences Announces Positive Phase 1 Data for Eganelisib in Relapsed/Refractory AML and Higher-Risk MDS in an Oral Presentation at ASCO 2026
disease-specific, functional, biological vulnerabilities and offer therapies that selectively target those biological vulnerabilities" said Manuel Aivado, MD, PhD, President and Chief Executive Officer of Stelexis BioSciences. "We believe that myeloid malignancies may find in PI3K-gamma an analog to HER2 in breast
More news about: Stelexis BioSciences, Inc.
Jun 02, 2026, 10:04 ET Statue Exhibit Features Women Using STEM to Power Sports at FIFA Fan Festival™ Dallas
Technology Product Manager (Dallas, TX)Alison Sheets-Singer, PhD, Biomechanics Researcher (Portland, OR)Amanda Alvarez Dieppa, PhD, Neuroscientist, Boxer, and Entrepreneur (Dallas, TX)Ambika Chandra, PhD, Turfgrass Breeder and Professor (Dallas, TX)Antonia F. Chen,
More news about: Lyda Hill Philanthropies’ IF/THEN® Initiative
Jun 02, 2026, 10:02 ET Karyopharm's Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis Selected for Late-Breaking Oral Presentation at EHA 2026
presented at EHA provide further support for the promising overall survival signal we saw in our Phase 3 SENTRY results," said Reshma Rangwala, MD, PhD, Chief Medical Officer and Head of Research of Karyopharm. "Collectively, this new analysis, when combined with our existing landmark analysis, provides
More news about: Karyopharm Therapeutics Inc.
Jun 02, 2026, 09:04 ET Invizix, Formerly Geminii Health Selected as Finalist in American Diabetes Association 2026 Innovation Challenge
research published in Cell Metabolism and has been recognized with the NIH Director's New Innovator Award. Invizix is led by Calvin Carter, PhD, and Sunny Huang, MD, PhD. Learn more at invizix.health.Forward-Looking StatementsThis press release contains forward-looking statements regarding
More news about: Invizix
Jun 02, 2026, 09:00 ET Health Foundation of South Florida to Host 2026 Black Health Summit Featuring National Medical Association President Dr. Roger A. Mitchell, Jr., MD
of Jackson North Medical Center and author of Informed and Engaged: Our Journey to Better Health. In conversation with Dr. M. Sandra Severe, PhD, MPH, Senior Vice President and CEO of Jackson North Medical Center, together they will discuss the importance of patient engagement, community partnership,
More news about: Health Foundation of South Florida
Jun 02, 2026, 09:00 ET Leukemia Research Foundation of Delaware Commits $1 million To Accelerate Pediatric Leukemia Research Through Blood Cancer United's Dare To Dream Project
research for pediatric patients must move forward with urgency and purpose."LRFDE's $1 million commitment will support research led by Alex Stevens, PhD, focused on improving treatment options for children with acute myeloid leukemia (AML), a rare and aggressive blood cancer. The funding is part of The
More news about: BLOOD CANCER UNITED, INC.
Jun 02, 2026, 08:59 ET Karyopharm to Present Results from Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis in Late-Breaking Oral Presentation at ASCO 2026 with Simultaneous Publication in the Journal of Clinical Oncology
highlight selinexor's differentiated mechanism of action and its potential to offer a complementary approach to JAK inhibition," said Reshma Rangwala, MD, PhD, Chief Medical Officer and Head of Research of Karyopharm. "Importantly, these findings reinforce the opportunity to target biological pathways beyond
More news about: Karyopharm Therapeutics Inc.
Jun 02, 2026, 08:48 ET Pictor® Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters
supported by long-term shareholders and a significant new U.S. investorWelcomed Terry Kelly, PhD, as Chief Operating Officer — bringing 20+ years in assay development, oncology, and neuroscience, a PhD from UCLA, and authorship on 30+ peer-reviewed publicationsWelcomed Tim Shannon as Chief
More news about: Pictor Holdings Inc.
Jun 02, 2026, 08:48 ET Pictor® Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters
supported by long-term shareholders and a significant new U.S. investorWelcomed Terry Kelly, PhD, as Chief Operating Officer — bringing 20+ years in assay development, oncology, and neuroscience, a PhD from UCLA, and authorship on 30+ peer-reviewed publicationsWelcomed Tim Shannon as Chief
More news about: Pictor Holdings Inc.
Jun 02, 2026, 08:36 ET Investors, Entrepreneurs, and Innovators Meet for Networking and Deal Flow at 23rd Annual What's Next Longevity Venture Summit
the Banatao Institute at UC Berkeley. Together they will offer programming and a certificate in AI and Longevity at the summit.Nathan Price, PhD, will deliver the keynote address. As a professor and co-director of the Center for Human Healthspan at the Buck Institute for Research on Aging, he
More news about: Mary Furlong & Associates
Jun 02, 2026, 08:30 ET De-Risk USP <665> Compliance for Single-Use Systems, Upcoming Webinar Hosted by Xtalks
risk assessment and screening method qualification can support compliant evaluation of single-use manufacturing components.Join James Scull, PhD, Chief Scientific Officer of Extractables & Leachables and Chemistry,
More news about: Xtalks
Jun 02, 2026, 08:15 ET Dr. Anna Maria Panasiuk Unveils Multi-Jurisdictional Blueprint After Shielding Investor from Devastating Tax Scheme
around is the critical difference between an investment and a liability."About Dr. Anna Maria PanasiukDr. Anna Maria Panasiuk (PhD, International Taxation) is a global wealth architect, Managing Partner of Panasiuk & Partners, and an appointed member of the Forbes Finance Council.
More news about: Anna Maria Panasiuk Advisory Services
Jun 02, 2026, 08:05 ET Subtle Medical Secures $33 Million in Growth Capital Led by Morgan Stanley Expansion Capital and Appoints Industry Veteran Ohad Arazi as CEO
scans on existing imaging systems, helping providers increase throughput without purchasing new hardware.Founded by Enhao Gong, PhD, and Greg Zaharchuk, MD, PhD, Professor of Neuroradiology at Stanford University, Subtle Medical helped pioneer the category of AI-powered image enhancement in radiology.
More news about: Subtle Medical, Inc.
Jun 02, 2026, 08:00 ET Converge Bio Secures $2.5M Grant to expand its fast-track AI gene discovery capabilities from pharma to growing climate-resilient crops
systems, leading to a U.S.-licensed patent and a scientific publication in collaboration with Nobel laureate Jennifer Doudna. CSO Iddo Weiner holds a PhD in Bioinformatics and Biomedical Engineering, and has led the development of two drug programs through positive Phase 2 clinical readouts. CTO Oded Kalev
More news about: Converge Bio
Jun 02, 2026, 07:00 ET NYU LANGONE HEALTH ANNOUNCES PLANS FOR A STATE-OF-THE-ART ACADEMIC MEDICAL CENTER IN MELVILLE
construction and beyond."This is one of the most ambitious and exciting projects ever undertaken by NYU Langone," said Alec C. Kimmelman, MD, PhD, dean and CEO of NYU Langone. "The benefits to Long Island—a community I grew up in, and one that our institution cares deeply about—will allow us to
More news about: NYU Langone Health System